Npd
Product Images NDC 57319-307

4 FDA label images from Phoenix Pharmaceutical, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Npd (NDC 57319-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neomycin Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 01)

Neomycin Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 01)
Chemical structure diagram of the active ingredient in the NPD product by Phoenix Pharmaceutical, Inc. The structure depicts a complex steroidal framework with several hydroxyl groups, carbonyl groups, and multiple ring systems.*
FDA Label Image

Neomycin Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 02)

Neomycin Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 02)
Chemical structure diagram of the active ingredients neomycin B and neomycin C, showing molecular components and substituent groups R1 and R2 with their different chemical compositions. The structure also indicates the presence of sulfate ions (HSO4).*
FDA Label Image

Polymyxin B Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 03)

Polymyxin B Sulfate (structural Formula) (2a1d77e9 C706 4d9b 9745 E93ef4919c8a 03)
Chemical structure diagram showing the composition of a polymyxin compound with repeating units involving DAB (2,4-diaminobutyric acid), threonine (THR), phenylalanine (PHE), and leucine (LEU) residues. It also indicates the presence of polymyxin B1R and B2R variants differing by a methylheptyl or methylhexyl group, along with associated sulfuric acid (xH2SO4).*
FDA Label Image

Npd Ophthalmic Ointment (preprinted Tube, 3.5 G (Phoenix))

Npd Ophthalmic Ointment (preprinted Tube, 3.5 G (Phoenix))
Label for NPD Ophthalmic Ointment containing Neomycin, Polymyxin B Sulfates, and Dexamethasone. The sterile ointment is for ophthalmic use only and has a net weight of 3.5 grams (1/8 oz). Manufactured for Phoenix Pharmaceutical, Inc., St. Joseph, MO, and labeled by Bausch & Lomb Incorporated, Tampa, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.